A boy with congenital analbuminemia and steroid-sensitive idiopathic nephrotic syndrome: an experiment of nature by Neuhaus, Thomas et al.
SHORT REPORT
A boy with congenital analbuminemia and steroid-sensitive
idiopathic nephrotic syndrome: an experiment of nature
Thomas J. Neuhaus & Thomas Stallmach &
Agnes Genewein
Received: 16 July 2007 /Accepted: 25 September 2007 /Published online: 19 October 2007
# Springer-Verlag 2007
Abstract In this paper, a boy is reported with the association
of congenital analbuminemia (CAA) and steroid-sensitive
idiopathic nephrotic syndrome (INS), two conditions resulting
independently in reduced colloid oncotic pressure. The unique
occurrence helps confirm earlier reports that albumin is not
the exclusive factor responsible for maintaining colloid
oncotic pressure.
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Introduction
Congenital analbuminemia (CAA) is a rare autosomal
recessive disorder [9] in which subjects have little or no
circulating serum albumin due to defective albumin synthe-
sis in the liver [23]. Fewer than 50 patients have been
recorded so far in the continuously updated Register of
Analbuminemia Cases [18]. Idiopathic nephrotic syndrome
(INS) has a prevalence of 1 in 6,000 children and is
characterized by hypoproteinemia, proteinuria, and edema.
Approximately 90% of children with INS respond to
steroids, and renal histology mainly shows minimal change
nephropathy [19]. The underlying pathogenetic mechanism
of INS is a defective glomerular permselectivity resulting in
albuminuria and hypoalbuminemia (<2.5 g/dl), leading to the
loss of serum oncotic pressure. We report a boy with the
incidental association of CAA and steroid-sensitive INS.
Case report
The male patient was born at term (37 week gestation), but
“small-for-gestational-age” with weight (2.2 kg) and length
(44 cm) <3rd percentile. Pregnancy had been complicated by
polyhydramnios. Mild peripheral edema was noted at three
days of age. Further investigations revealed moderate hypo-
proteinemia (3.5 g/dl) and marked hypoalbuminemia (1.4 g/dl).
At the age of ninemonths, the diagnosis of CAAwas confirmed
with serum albumin persistently below 0.2 g/dl; urinalysis and
fecal concentration of alpha1-antitrypsin were normal, making
urinary or enteral loss unlikely. At the age of four years, serum
proteins (agarose gel electrophoresis) and lipids were as shown
in Table 1: albumin was very low; alpha 1 globulins (main
constituents: α1-lipoprotein, α1-glycoprotein, α1-antitrypsin),
alpha 2 globulins (α2-macroglobulin, pre-β-lipoprotein, hap-
toglobin), and beta globulins (transferrin, β-lipoprotein,
complement) were elevated; gamma globulins, IgG, IgA,
IgM were normal; total and LDL cholesterol (enzymatic
analysis) were markedly elevated, HDL cholesterol was just
above reference range; lipoprotein(a) and triglycerides (turbi-
dimetric analysis) were elevated; there was no proteinuria. The
further clinical course was uneventful apart from recurrent
mild upper respiratory tract infections associated twice with a
febrile convulsion; an electroencephalogram was normal.
When the DNA sequence analysis of the human albumin
gene became available, a C→T substitution at nucleotide
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4446 was identified in the proband [4]. The mutation
changes the codon CGA for Arg 114 to a stop codon TGA,
resulting in premature termination and is responsible for the
analbuminemic trait. The putative protein product, called
Albumin Zurich, would have a length of 113 residues.
At the age of 5 years, he was admitted to our hospital
because the parents had noticed swelling of the legs and a
weight gain of 2 kg during the previous month. Clinical
examination showed blood pressure in the upper normal
range (110/70 mm Hg) and, apart from swelling of the legs
and the face, no further abnormalities, in particular, no
evidence of hypovolemia. Height and weight were 111 cm
(50th percentile) and 23 kg (90th–97th percentile), respec-
tively. On the assumption that the clinical condition was
caused by the CAA, the patient was given immediately
after admission (defined as day 0) a single dose of albumin
intravenously (i.e., 100 ml of albumin 20%; purity of
albumin ≥96%). Urine had been routinely collected before
albumin was given, but the result was noticed only after the
albumin infusion had been administered and unexpectedly
revealed proteinuria (2+ on Combur Stix®, Roche, Basel,
Switzerland). Combur Stix® is highly sensitive, but not
specific for albumin, detecting also for other proteins. There
was no hematuria. Further serum and urinary laboratory
investigations were performed on day 1, i.e., after the
albumin infusion (Table 1). Renal function, assessed as
plasma creatinine (0.4 mg/dl; Jaffé method), and sodium
were normal.
Serum albumin rose on day 1, i.e., 8 h after the albumin
infusion, to a maximum concentration of 11.6 g/l and
returned to baseline on day 10 with an estimated serum
half-life (T1/2) of <5 days. Serum alpha 2 globulins and
cholesterol showed a transient increase from baseline; in
contrast, alpha 1 globulins, beta globulins and gamma
globulins, and IgG were transiently decreased. Twenty-
four-hour proteinuria on day 1 consisted mainly of albumin.
On day 10, proteinuria persisted, but albuminuria was
almost absent and the main urinary protein constituents
Table 1 Biochemical parameters in serum and urine
Date Normal range (aged at 4 years) Age
4 years
Age 5 years: INS Age 11 years 2007
Day 1* Day 10 Day 37**
Serum
Total protein: g/l 60–80 46*** 40 41 54 50
Albumin: g/l 37–45 2.6 11.6* 2.4 2.6 1.1
Alpha 1 globulins: g/l 1.2–2.8 4.5 1.8 3.2 5.9 4.7
Alpha 2 globulins: g/l 4.3–8.3 13.9 15.0 19.1 19.0 16.6
Beta globulins: g/l 4.9–8.1 15.4 9.5 12.9 20.3 18
Gamma globulins: g/l 4.9–10.5 9.6 2.1 3.4 6.3 9.7
Total IgG: g/l 6–12 8.0 1.5 1.9 5.1 8.9
IgG1 4–11 1.1 5.7
IgG2 0.85–4.1 1.1 2.7
IgG3 0.13–1.42 0.3 0.7
IgG4 0.03–1.89 0.2 0.6
IgA: g/l 0.5–2 1.9 1.6 2.2 2.4
IgM: g/l 0.5–1.5 1.1 0.9 1.5 1.0
Sodium: mmol/l 135–145 137 137 139 137 139
Cholesterol: mmol/l 1.6–4.9 12.3 18.9 17.2 20.4 13.8
HDL-cholesterol 1.0–1.3 1.6 1.1
LDL-cholesterol 2.9–4.9 9.7 11
Apo-lipoprotein A1: g/l 1.1–1.8 1.3
Apo-lipoprotein B: g/l 0.6–1.4 2.8
Lipoprotein (a): g/l <0.56 2.0 4.4
Triglycerides: mmol/l 0.5–1.6 2.2 4.0 3.7 3.6
Urinary excretion: g/24 h
Protein 0 4.2 3.1 0 0
Albumin 0 3.0 0.1 0 0
Alpha 1 globulins 0 0.7 1.4 0 0
Alpha 2 globulins 0 0.1 0.5 0 0
Beta globulins 0 0.3 0.8 0 0
Gamma globulins 0 0.1 0.3 0 0
*Day 1=after the administration of albumin 20 g i.v. on day 0; **Day 37=in remission; ***All results outside reference range in bold
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(agarose gel electrophoresis) were alpha 1 and beta
globulins. Qualitative sodium dodecyl sulfate polyacryl-
amide gel (SDS-PAGE) urinary electrophoresis on day 1
and day 10 revealed also transferrin, IgG, IgM, and
complement C3.
The presumptive diagnosis was idiopathic nephrotic
syndrome (INS). However, since hypoalbuminemia as a
diagnostic hallmark of INS was difficult to interpret in the
context of CAA, a renal biopsy was performed on day 5.
Light microscopy showed 14 normally structured glomeruli
and immunofluorescence was negative; electron microsco-
py revealed effacement of foot processes involving about
80% of the glomerular capillary circumferences, leading to
the diagnosis of minimal change nephropathy (Fig. 1). On
day 6, oral prednisone (40 mg per day) was started. On day
21, the patient came into remission (i.e., no proteinuria). On
day 37, a detailed analysis of serum and urine was repeated
(Table 1). Prednisone was continued for six weeks and was
then switched to 25 mg on alternate days for a further six
weeks. No relapse of the INS has occurred so far.
Currently, at the age of 11 years, the boy is healthy apart
from occasional mild infections of the upper airways. Blood
pressure (95/60 mm Hg), height (144.5 cm, 25th–50th
percentile), and weight (40.8 kg; 75th centile) are normal,
and there is no peripheral edema. The serum protein and
lipid pattern is identical to the results obtained at 4 years of
age; urinalysis shows no proteinuria (Table 1). X-rays of the
hands and knees reveal normal osseous structure. The non-
consanguineous Swiss parents, heterozygous for the C→T
substitution at nucleotide 4446 [4], are healthy and have a
slightly decreased serum albumin concentration (father:
32 g/dl; mother: 36 g/dl). Family history is negative for
miscarriages or neonatal deaths.
Discussion
This report describes a boy with CAA and steroid-sensitive
INS, a unique association of two conditions resulting
independently in reduced colloid oncotic blood pressure.
CAA is a rare autosomal recessive disorder [4, 9, 18, 21],
leading to defective albumin synthesis in the liver [23],
with subsequent very low serum albumin concentration
(<2 g/dl). If albumin is administered intravenously to
patients with CAA, its biologic half-life is prolonged to
38–50 days (reference range: 16–20 days) [21, 23]; on the
contrary, the half-life in our patient was very short
(<5 days), raising the question of albuminuria.
Colloid oncotic blood pressure in healthy individuals is
mainly maintained by serum albumin (normal range: 26–
31 mm Hg) [12, 20]. The oncotic pressure in patients with
CAA is persistently decreased to about half of its normal
value [12, 16]. Marked edema, however, is absent, and only
half of these patients present with mild peripheral edema,
indicating the presence of edema-preventive measures
(reviewed in 12, 16]). Increased concentrations of non-
albumin proteins (mainly alpha 1, alpha 2, and beta
globulins) [8, 12, 23] and lipoproteins [8, 12, 16, 21], and
lowering in parallel of the interstitial oncotic pressure
through washout of interstitial colloids and increased lymph
drainage, mitigate the effect on the capillary oncotic
pressure and the transcapillary oncotic gradient [8, 12,
16]. In addition, there is a reduction of the hydrostatic
pressure gradient by lowering the capillary blood pressure
and increasing the interstitial pressure [14]. Experimental
data on the effect of hypoalbuminemia on the capillary
permeability are controversial. Wraight [24] showed a
decreased glomerular permeability to proteins in rats made
acutely hypoalbuminemic after plasmapheresis, whereas
Fujihara et al. [6] demonstrated enhanced glomerular
permeability to macromolecules in the (chronic) analbumi-
nemic Nagase rat. When our patient was in remission, he
had no proteinuria, suggesting that permeability for macro-
molecules was not enhanced.
Children with INS present with marked edema, typically
resulting in weight gain. Proteinuria mainly consists of
albumin, but other proteins, including transferrin [3] and
gamma globulins (IgG, subclasses) [1, 17], are also lost in
the urine, though to a much lesser extent. Albuminuria and
hypoalbuminemia result in the acute reduction of colloid
oncotic pressure, with low values (≤12 mm Hg) [20]
comparable to patients with CAA. This leads—at least in a
subgroup of children with steroid-sensitive INS—to hypo-
volemia and secondary activation of the renin-angiotensin-
aldosterone axis, the sympathetic nervous system, and
vasopressin secretion with subsequent edema formation,
consistent with the “underfilling” hypothesis (summarized
in [20]). However, most studies from (mainly adult) patients
Fig. 1 Renal biopsy. Electron micrograph of a portion of a
glomerulus with effacement of foot processes (arrows) and the
vacuolization of podocytes (asterisks). (Uranyl acetate and lead
citrate; ×7,500)
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with the nephrotic syndrome have failed to find a consistent
reduction in blood and plasma volume, suggesting primary
renal sodium retention [14, 20]. In addition to renal
molecular mechanisms, increased hydraulic conductivity
due to the transconformation of endothelial intercellular
junctions driving the leakage of fluid into the interstitium has
been suggested [5]. Immune mechanisms related to the
release of cytokines in INS, leading to generalized vascular
hyperpermeability, have also been postulated [15]. The role
of circulating vascular endothelial growth factor (VEGF) is,
however, controversial [2, 22].
The defense mechanisms in nephrotic syndrome against
edema formation are, at least partially, similar to CAA, i.e.,
lowering in parallel of the interstitial oncotic pressure through
washout of interstitial colloids and increased lymph drainage,
and reduction of the hydrostatic pressure gradient by lowering
the capillary blood pressure and increasing the interstitial
pressure [14, 20]. Additional defense mechanisms in children
with INS and concomitant hypovolemia and hyponatremia
(both not present in our patient) include unidentified
endogenous osmoles [10, 13]. The colloid oncotic pressure
in patients with CAA and INS is comparable. Whereas the
low oncotic pressure state is a chronic condition in CAA,
allowing for effective edema-preventive measures, the
pressure changes occur very fast in INS and, thus, preclude
successful defensive mechanisms.
The question, however, arises as to why this patient with
INS and CAA did develop edema at all, as the CAA makes
the usual cause for edema irrelevant. In fact, the clinical
presentation of the INS, i.e., the extent of edema, in this
patient was mild. We hypothesize that at least two
mechanisms might have contributed.
Firstly, some of the serum proteins in patients with CAA
compensating for the low albumin have a higher MW than
albumin (MW 66 kD) [7], in particular, the main constituents
of alpha 2 globulins (α2-macroglobulin: MW 725 kD; pre-
β-lipoprotein: MW>3,000 kD; haptoglobin: MW 100 kD)
[7], precluding major glomerular filtration. In fact, serum
alpha 2 globulins were elevated during the INS, thereby,
“defending” oncotic pressure. In contrast to alpha 2
globulins, two other non-albumin constituents maintaining
oncotic pressure in CAA, i.e., alpha 1 and beta globulins,
have MW comparable to albumin (α1-glycoprotein: MW
55 kD, α1-antitrypsin: MW 50 kD; transferrin: MW 77 kD)
[7]. They were the main urinary protein constituents during
the INS and their serum concentrations were decreased,
leading to reduced oncotic pressure. Typically for minimal-
change nephropathy, and often in contrast to focal segmental
glomerulosclerosis, only a small amount of gamma globulins
(≪1 g/d) was lost in the urine [1]. The main cause of
hypogammaglobulinemia during a relapse of INS is not
urinary loss, but a primary immunological mechanism, and
low serum IgG persists for months after remission [11].
Secondly, the additional reduction of the colloid oncotic
pressure, superimposed on an already low baseline oncotic
pressure, might have exerted only a minor effect. As
expected in INS, the serum cholesterol showed a transient
increase beyond the highly elevated baseline concentration.
A few publications have reviewed the clinical presentation
and long-term outcome of patients with CAA [8, 9, 12, 16,
21]. However, the follow-up data are incomplete and
inconsistent in some cases. Thus, despite the very high
serum concentrations of total and LDL cholesterol, the risk
of progressive atherosclerosis and cardiovascular events is
still not well defined; yet, an increased risk of atherosclerosis
cannot be excluded [8, 9, 12, 16, 21]. Well-documented
complications were lipodystrophy (mainly in adult females)
and osteoporosis. Neonatal presentation occasionally included
low birth weight (“small-for-gestational-age”) and mild
peripheral edema. Apart from recurrent mild respiratory
infections, no additional clinical findings were observed in
children. In contrast to the benign outcome after birth, the
prenatal course of affected fetuses appears less favorable as
maternal miscarriages and neonatal deaths were reported in
family histories [12, 21].
We conclude that experiments of the nature—the unique
association of congenital analbuminemia and idiopathic
nephrotic syndrome—helps confirm that serum albumin is
not the exclusive factor responsible for maintaining oncotic
pressure. The precise information on the transient changes
of various proteins in blood and urine might contribute to a
better understanding of both conditions.
References
1. Adamson O, Trachtman H, Tejani A (1986) Urinary protein
electrophoresis patterns in childhood idiopathic nephrotic syn-
drome. Int J Pediatr Nephrol 7:181–186
2. Boner G, Cox AJ, Kelly DJ, Tobar A, Bernheim J, Langham RG,
Cooper ME, Gilbert RE (2003) Does vascular endothelial growth
factor (VEGF) play a role in the pathogenesis of minimal change
disease? Nephrol Dial Transplant 18:2293–2299
3. Brocklebank T, Cooper EH, Richmond K (1991) Sodium dodecyl
sulphate polyacrylamide gel electrophoresis patterns of proteinuria
in various renal diseases of childhood. Pediatr Nephrol 5:371–375
4. Campagnoli M, Sala A, Labo S, Rossi A, Neuhaus TJ, Braegger
CP, Minchiotti L, Galliano M (2005) Analbuminemia in a Swiss
family is caused by a C –> T transition at nucleotide 4446 of the
albumin gene. Clin Biochem 38:819–823
5. Deschênes G, Guigonis V, Doucet A (2004) Molecular mecha-
nism of edema formation in nephrotic syndrome. Arch Pediatr
11:1084–1094
6. Fujihara CK, Arcos-Fajardo M, Brandão De Almeida Prado E,
José Brandão De Almeida Prado M, Sesso A, Zatz R (2002)
Enhanced glomerular permeability to macromolecules in the Nagase
analbuminemic rat. Am J Physiol Renal Physiol 282:F45–F50
7. Ciba-Geigy (1979) Geigy Scientific Tables, 8th edn. Ciba-Geigy,
Basel, Switzerland
8. Gossi B, Kleinert D, Gossi U (2000) A further case of
analbuminemia. Schweiz Med Wochenschr 130:583–589
1076 Eur J Pediatr (2008) 167:1073–1077
9. Kallee E (1996) Bennhold’s analbuminemia: a follow-up study of
the first two cases (1953–1992). J Lab Clin Med 127:470–480
10. Kapur G, Valentini RP, Imam AA, Jain A, Mattoo TK (2007)
Serum osmolal gap in patients with idiopathic nephrotic syndrome
and severe edema. Pediatrics 119:e1404–e1407
11. Kemper MJ, Altrogge H, Ganschow R, Müller-Wiefel DE (2002)
Serum levels of immunoglobulins and IgG subclasses in steroid
sensitive nephrotic syndrome. Pediatr Nephrol 17(6):413–417
12. Koot BGP, Houwen R, Pot D-J, Nauta J (2004) Congenital
analbuminaemia: biochemical and clinical implications. A case
report and literature review. Eur J Pediatr 163:664–670
13. Nguyen MK, Kurtz I (2004) New insights into the pathophysiol-
ogy of the dysnatremias: a quantitative analysis. Am J Physiol
Renal Physiol 287:F172–F180
14. Palmer BF, Alpern RJ (1997) Pathogenesis of edema formation in
the nephrotic syndrome. Kidney Int Suppl 59:S21–S27
15. Rostoker G, Behar A, Lagrue G (2000) Vascular hyperperme-
ability in nephrotic edema. Nephron 85:194–200
16. Russi E, Weigand K (1983) Analbuminemia. Klin Wochenschr
61:541–545
17. Taylor GM, Neuhaus TJ, Shah V, Dillon S, Barratt TM (1997)
Charge and size selectivity of proteinuria in children with
idiopathic nephrotic syndrome. Pediatr Nephrol 11:404–410
18. The Albumin web site. Home page at http://www.albumin.org
19. [No authors listed] (1981) The primary nephrotic syndrome in
children. Identification of patients with minimal change nephrotic
syndrome from initial response to prednisone. A report of the
International Study of Kidney Disease in Children. J Pediatr
98:561–564
20. Vande Walle JGJ, Donckerwolcke RA (2001) Pathogenesis of
edema formation in the nephrotic syndrome. Pediatr Nephrol
16:283–293
21. Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW
(1994) Analbuminemia: three cases resulting from different point
mutations in the albumin gene. Proc Natl Acad Sci USA 91:9417–
9421
22. Webb NJA, Watson CJ, Roberts ISD, Bottomley MJ, Jones CA,
Lewis MA, Postlethwaite RJ, Brenchley PEC (1999) Circulating
vascular endothelial growth factor is not increased during relapses
of steroid-sensitive nephrotic syndrome. Kidney Int 55:1063–
1071
23. Weinstock JV, Kawanishi H, Sisson J (1979) Morphologic,
biochemical and physiologic alterations in a case of idiopathic
hypoalbuminemia (analbuminemia). Am J Med 67:132–139
24. Wraight EP (1974) Capillary permeability to protein as a factor in
the control of plasma volume. J Physiol 237:39–47
Eur J Pediatr (2008) 167:1073–1077 1077
